Pharmaron Beijing board to meet on Q3 2025 results

Pharmaron Beijing Co., Ltd. has announced that its board of directors will convene on Tuesday, October 28, 2025. The primary agenda for this meeting includes the review and approval of the company's and its subsidiaries' third-quarter results for the nine months ended September 30, 2025. This notice was issued from Beijing, People's Republic of China, on October 14, 2025.

The current board of directors comprises executive directors Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei. Non-executive directors include Mr. Li Jiaqing and Ms. Wan Xuan. Additionally, the independent non-executive directors are Ms. Li Lihua, Mr. Zeng Kunhong, and Mr. Yu Jian. Dr. Lou Boliang serves as the chairman of the board.